{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:40:40Z","timestamp":1782895240220,"version":"3.54.5"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.7759\/cureus.111861","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:34:22Z","timestamp":1782891262000},"source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of the Potential Impact of Next-Generation Tobacco and Nicotine Products on Cardiovascular Health"],"prefix":"10.7759","author":[{"given":"Ian M","family":"Fearon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nahde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. The Tobacco Atlas. health effects. (2025). Accessed: 6th November 2025: https:\/\/tobaccoatlas.org\/challenges\/health-effects\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100291","article-title":"Cardiovascular disease prevention: risk factor modification at the heart of the matter","volume":"17","author":"Fawzy AM","year":"2021","unstructured":"Fawzy AM, Lip GY. Cardiovascular disease prevention: risk factor modification at the heart of the matter. Lancet Reg Health West Pac. 2021, 17:100291. 10.1016\/j.lanwpc.2021.100291","journal-title":"Lancet Reg Health West Pac"},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. health effects of cigarettes: cardiovascular disease. (2024). Accessed: 4th November 2025: https:\/\/www.cdc.gov\/tobacco\/about\/cigarettes-and-cardiovascular-disease.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5855","article-title":"Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports","volume":"360","author":"Hackshaw A","year":"2018","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018, 360:j5855. 10.1136\/bmj.j5855","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1351-4","article-title":"Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study","volume":"17","author":"Banks E","year":"2019","unstructured":"Banks E, Joshy G, Korda RJ, et al.. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC Med. 2019, 17:128. 10.1186\/s12916-019-1351-4","journal-title":"BMC Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004561","article-title":"Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: the Cross-Cohort Collaboration (CCC)","volume":"22","author":"Tasdighi E","year":"2025","unstructured":"Tasdighi E, Yao Z, Dardari ZA, et al.. Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: the Cross-Cohort Collaboration (CCC). PLoS Med. 2025, 22:e1004561. 10.1371\/journal.pmed.1004561","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1399","article-title":"Cardiovascular effects of smoking and smoking cessation: a 2024 Update","volume":"20","author":"Rahman M","year":"2025","unstructured":"Rahman M, Alatiqi M, Al Jarallah M, Hussain MY, Monayem A, Panduranga P, Rajan R. Cardiovascular effects of smoking and smoking cessation: a 2024 Update. Glob Heart. 2025, 20:15. 10.5334\/gh.1399","journal-title":"Glob Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/1462220021000018380","article-title":"Influence of long-term smoking reduction on health risk markers and quality of life","volume":"4","author":"Bolliger CT","year":"2002","unstructured":"Bolliger CT, Zellweger JP, Danielsson T, et al.. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res. 2002, 4:433-9. 10.1080\/1462220021000018380","journal-title":"Nicotine Tob Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci G","year":"2020","unstructured":"Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020, 12:3866-76. 10.21037\/jtd.2020.02.47","journal-title":"J Thorac Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature06796","article-title":"Translating molecular discoveries into new therapies for atherosclerosis","volume":"451","author":"Rader DJ","year":"2008","unstructured":"Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008, 451:904-13. 10.1038\/nature06796","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross R","year":"1993","unstructured":"Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993, 362:801-9. 10.1038\/362801a0","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross R","year":"1999","unstructured":"Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340:115-26. 10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"ref14","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi HA","year":"2005","unstructured":"Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005, 1:183-98.","journal-title":"Vasc Health Risk Manag"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby P","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002, 105:1135-43. 10.1161\/hc0902.104353","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000097769.47306.12","article-title":"Regulation of superoxide anion production by NADPH oxidase in monocytes\/macrophages: contributions to atherosclerosis","volume":"24","author":"Cathcart MK","year":"2004","unstructured":"Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes\/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol. 2004, 24:23-8. 10.1161\/01.ATV.0000097769.47306.12","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2006.11.005","article-title":"Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury","volume":"17","author":"Papaharalambus CA","year":"2007","unstructured":"Papaharalambus CA, Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med. 2007, 17:48-54. 10.1016\/j.tcm.2006.11.005","journal-title":"Trends Cardiovasc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.159178","article-title":"Oxidative stress and platelets","volume":"28","author":"Freedman JE","year":"2008","unstructured":"Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008, 28:s11-6. 10.1161\/ATVBAHA.107.159178","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina E","year":"2007","unstructured":"Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007, 27:2292-301. 10.1161\/ATVBAHA.107.149179","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.05.013","article-title":"Oxidative stress and cardiovascular disease: novel tools give (free) radical insight","volume":"47","author":"Fearon IM","year":"2009","unstructured":"Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol. 2009, 47:372-81. 10.1016\/j.yjmcc.2009.05.013","journal-title":"J Mol Cell Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai H","year":"2000","unstructured":"Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000, 87:840-4. 10.1161\/01.res.87.10.840","journal-title":"Circ Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000261970.18328.1d","article-title":"Endothelial mitochondria: contributing to vascular function and disease","volume":"100","author":"Davidson SM","year":"2007","unstructured":"Davidson SM, Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res. 2007, 100:1128-41. 10.1161\/01.RES.0000261970.18328.1d","journal-title":"Circ Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000258450.44413.96","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"100","author":"Madamanchi NR","year":"2007","unstructured":"Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007, 100:460-73. 10.1161\/01.RES.0000258450.44413.96","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119076","article-title":"Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability","volume":"98","author":"Rajagopalan S","year":"1996","unstructured":"Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996, 98:2572-9. 10.1172\/JCI119076","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/BF02620873","article-title":"Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60","volume":"24","author":"Cathcart MK","year":"1988","unstructured":"Cathcart MK, Chisolm GM 3rd, McNally AK, Morel DW. Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60. In Vitro Cell Dev Biol. 1988, 24:1001-8. 10.1007\/BF02620873","journal-title":"In Vitro Cell Dev Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.38.2.341","article-title":"Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic","volume":"38","author":"Cathcart MK","year":"1985","unstructured":"Cathcart MK, Morel DW, Chisolm GM 3rd. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985, 38:341-50. 10.1002\/jlb.38.2.341","journal-title":"J Leukoc Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108718","article-title":"Enhancement of platelet function by superoxide anion","volume":"59","author":"Handin RI","year":"1977","unstructured":"Handin RI, Karabin R, Boxer GJ. Enhancement of platelet function by superoxide anion. J Clin Invest. 1977, 59:959-65. 10.1172\/JCI108718","journal-title":"J Clin Invest"},{"key":"ref28","article-title":"Pathways of oxygen utilization by stimulated platelets and leukocytes","volume":"16","author":"Marcus AJ","year":"1979","unstructured":"Marcus AJ. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hematol. 1979, 16:188-95.","journal-title":"Semin Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pecs.2006.01.001","article-title":"Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health","volume":"32","author":"Baker RR","year":"2006","unstructured":"Baker RR. Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health. Progress Energ Combust Sci. 2006, 32:373-85. 10.1016\/j.pecs.2006.01.001","journal-title":"Progress Energ Combust Sci"},{"key":"ref30","article-title":"The Chemical Components of Tobacco and Tobacco Smoke","author":"Rodgman A","year":"2013","unstructured":"Rodgman A, Perfetti T. The Chemical Components of Tobacco and Tobacco Smoke. CRC Press, Boca Raton; 2013."},{"key":"ref31","unstructured":"Food and Drug Administration. harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. (2012). Accessed: 4th November 2025: https:\/\/www.federalregister.gov\/documents\/2012\/04\/03\/2012-7727\/harmful-and-potentially-harmful-constituents-in-tobacc...."},{"key":"ref32","unstructured":"Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. cardiovascular diseases. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. (2010). Accessed: 9th November 2025: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53017\/."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0518-9_ch4","article-title":"Tobacco and cardiovascular disease: a summary of evidence","author":"Roy A","year":"2017","unstructured":"Roy A, Rawal I, Jabbour S, Prabhakaran D. Tobacco and cardiovascular disease: a summary of evidence. Cardiovascular, Respiratory, and Related Disorders. Disease Control Priorities (Third Edition). Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R (ed): The International Bank for Reconstruction and Development \/ The World Bank, Washington, DC; 2017. 5:10.1596\/978-1-4648-0518-9_ch4"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2025.1554747","article-title":"An adverse outcome pathway for cigarette smoke-mediated oxidative stress in plaque formation","volume":"7","author":"Makena P","year":"2025","unstructured":"Makena P, Haswell LE, McEwan M, et al.. An adverse outcome pathway for cigarette smoke-mediated oxidative stress in plaque formation. Front Toxicol. 2025, 7:1554747. 10.3389\/ftox.2025.1554747","journal-title":"Front Toxicol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2006.12.017","article-title":"Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension","volume":"20","author":"Rhee MY","year":"2007","unstructured":"Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens. 2007, 20:637-41. 10.1016\/j.amjhyper.2006.12.017","journal-title":"Am J Hypertens"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.36","article-title":"Cardiovascular effects of electronic cigarettes","volume":"14","author":"Benowitz NL","year":"2017","unstructured":"Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017, 14:447-56. 10.1038\/nrcardio.2017.36","journal-title":"Nat Rev Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14248717","article-title":"Impact of nicotine-free electronic cigarettes on cardiovascular health: a systematic review","volume":"14","author":"Jukic I","year":"2025","unstructured":"Jukic I, Becic T, Matulic I, Simac P, Vukovic J. Impact of nicotine-free electronic cigarettes on cardiovascular health: a systematic review. J Clin Med. 2025, 14:10.3390\/jcm14248717","journal-title":"J Clin Med"},{"key":"ref38","article-title":"","author":"McNeil A","year":"2018","unstructured":"McNeil A, Brose LS, Calder R, Bauld L, Robson D. Evidence Review of E-Cigarettes and Heated Tobacco Products 2018. Public Health England, London; 2018. https:\/\/www.gov.uk\/government\/publications\/e-cigarettes-and-heated-tobacco-products-evidence-review."},{"key":"ref39","article-title":"Nicotine without Smoke: Tobacco Harm Reduction - A Report by the Tobacco Advisory Group of the Royal College of Physicians","author":"Royal College of Physicians","year":"2016","unstructured":"Royal College of Physicians. Nicotine without Smoke: Tobacco Harm Reduction - A Report by the Tobacco Advisory Group of the Royal College of Physicians. Royal College of Physicians, London; 2016."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61223","article-title":"The product science of electrically heated tobacco products: an updated narrative review of the scientific literature","volume":"16","author":"Cordery S","year":"2024","unstructured":"Cordery S, Thompson K, Stevenson M, et al.. The product science of electrically heated tobacco products: an updated narrative review of the scientific literature. Cureus. 2024, 16:e61223. 10.7759\/cureus.61223","journal-title":"Cureus"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1630961","article-title":"Assessing biomarkers of exposure to carcinogens associated with combustible cigarettes, electronic cigarettes, and heated tobacco products: a systematic review and meta-analysis","volume":"16","author":"Cao Y","year":"2025","unstructured":"Cao Y, Zhang L, Yang M, et al.. Assessing biomarkers of exposure to carcinogens associated with combustible cigarettes, electronic cigarettes, and heated tobacco products: a systematic review and meta-analysis. Front Pharmacol. 2025, 16:1630961. 10.3389\/fphar.2025.1630961","journal-title":"Front Pharmacol"},{"key":"ref42","article-title":"Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction","author":"Institute of Medicine","year":"2001","unstructured":"Institute of Medicine. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. National Academy Press, Washington, D.C.; 2001. https:\/\/www.nationalacademies.org\/read\/10029."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/tc.10.2.189","article-title":"Clearing the smoke: the science base for tobacco harm reduction--executive summary","volume":"10","author":"Stratton K","year":"2001","unstructured":"Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tob Control. 2001, 10:189-95. 10.1136\/tc.10.2.189","journal-title":"Tob Control"},{"key":"ref44","article-title":"Medicine: Public Health Consequences of E-Cigarettes","author":"National Academies of Sciences E","year":"2018","unstructured":"National Academies of Sciences E. Public Health Consequences of E-Cigarettes: 2018. National Academy Press, Washington, D.C.; 2018. https:\/\/www.nap.edu\/catalog\/24952\/public-health-consequences-of-e-cigarettes."},{"key":"ref45","unstructured":"World Health Organization. The Tobacco Atlas. E-cigarettes and HTPs. (2025). Accessed: 6th November 2025: https:\/\/tobaccoatlas.org\/challenges\/e-cigarettes-htps\/."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54228","article-title":"Tobacco-free nicotine pouches and their potential contribution to tobacco harm reduction: a scoping review","volume":"16","author":"Grandolfo E","year":"2024","unstructured":"Grandolfo E, Ogden H, Fearon IM, Malt L, Stevenson M, Weaver S, Nahde T. Tobacco-free nicotine pouches and their potential contribution to tobacco harm reduction: a scoping review. Cureus. 2024, 16:e54228. 10.7759\/cureus.54228","journal-title":"Cureus"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae131","article-title":"The potential impact of oral nicotine pouches on public health: a scoping review","volume":"27","author":"Travis N","year":"2025","unstructured":"Travis N, Warner KE, Goniewicz ML, et al.. The potential impact of oral nicotine pouches on public health: a scoping review. Nicotine Tob Res. 2025, 27:598-610. 10.1093\/ntr\/ntae131","journal-title":"Nicotine Tob Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.105117","article-title":"The health effects of vaping and e-cigarettes: consensus recommendations","volume":"148","author":"Kouzoukas E","year":"2026","unstructured":"Kouzoukas E, Navas C, Zawertailo L, et al.. The health effects of vaping and e-cigarettes: consensus recommendations. Int J Drug Policy. 2026, 148:105117. 10.1016\/j.drugpo.2025.105117","journal-title":"Int J Drug Policy"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2012.08.018","article-title":"In vitro models for assessing the potential cardiovascular disease risk associated with cigarette smoking","volume":"27","author":"Fearon IM","year":"2013","unstructured":"Fearon IM, Ga\u00e7a MD, Nordskog BK. In vitro models for assessing the potential cardiovascular disease risk associated with cigarette smoking. Toxicol In Vitro. 2013, 27:513-22. 10.1016\/j.tiv.2012.08.018","journal-title":"Toxicol In Vitro"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/em.20441","article-title":"Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization","volume":"50","author":"Chen HW","year":"2009","unstructured":"Chen HW, Lii CK, Ku HJ, Wang TS. Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization. Environ Mol Mutagen. 2009, 50:96-104. 10.1002\/em.20441","journal-title":"Environ Mol Mutagen"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1080\/00365510701283878","article-title":"Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease","volume":"67","author":"Halvorsen B","year":"2007","unstructured":"Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest. 2007, 67:604-11. 10.1080\/00365510701283878","journal-title":"Scand J Clin Lab Invest"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2288","article-title":"A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease","volume":"136","author":"Reichert V","year":"2009","unstructured":"Reichert V, Xue X, Bartscherer D, et al.. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest. 2009, 136:212-9. 10.1378\/chest.08-2288","journal-title":"Chest"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2017.06.001","article-title":"A comparative assessment of e-cigarette aerosols and cigarette smoke on in vitro endothelial cell migration","volume":"277","author":"Taylor M","year":"2017","unstructured":"Taylor M, Jaunky T, Hewitt K, Breheny D, Lowe F, Fearon IM, Gaca M. A comparative assessment of e-cigarette aerosols and cigarette smoke on in vitro endothelial cell migration. Toxicol Lett. 2017, 277:123-8. 10.1016\/j.toxlet.2017.06.001","journal-title":"Toxicol Lett"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10105146","article-title":"Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells","volume":"10","author":"Farsalinos KE","year":"2013","unstructured":"Farsalinos KE, Romagna G, Allifranchini E, et al.. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013, 10:5146-62. 10.3390\/ijerph10105146","journal-title":"Int J Environ Res Public Health"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2022.747508","article-title":"Use of human induced pluripotent stem cell-derived cardiomyocytes to predict the cardiotoxicity potential of next generation nicotine products","volume":"4","author":"Simms L","year":"2022","unstructured":"Simms L, Yu F, Palmer J, et al.. Use of human induced pluripotent stem cell-derived cardiomyocytes to predict the cardiotoxicity potential of next generation nicotine products. Front Toxicol. 2022, 4:747508. 10.3389\/ftox.2022.747508","journal-title":"Front Toxicol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221088996","article-title":"A comparative assessment of e-cigarette aerosol extracts and tobacco cigarette smoke extracts on in vitro endothelial cell inflammation response","volume":"41","author":"Su L","year":"2022","unstructured":"Su L, Zhao M, Ma F, et al.. A comparative assessment of e-cigarette aerosol extracts and tobacco cigarette smoke extracts on in vitro endothelial cell inflammation response. Hum Exp Toxicol. 2022, 41:9603271221088996. 10.1177\/09603271221088996","journal-title":"Hum Exp Toxicol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105510","article-title":"Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette","volume":"86","author":"Chapman F","year":"2023","unstructured":"Chapman F, Sticken ET, Wieczorek R, et al.. Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette. Toxicol In Vitro. 2023, 86:105510. 10.1016\/j.tiv.2022.105510","journal-title":"Toxicol In Vitro"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2020.07.011","article-title":"Evaluation of a high-throughput in vitro endothelial cell migration assay for the assessment of nicotine and tobacco delivery products","volume":"334","author":"Bishop E","year":"2020","unstructured":"Bishop E, Breheny D, Hewitt K, et al.. Evaluation of a high-throughput in vitro endothelial cell migration assay for the assessment of nicotine and tobacco delivery products. Toxicol Lett. 2020, 334:110-6. 10.1016\/j.toxlet.2020.07.011","journal-title":"Toxicol Lett"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2021.08.003","article-title":"Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes","volume":"2","author":"Simms L","year":"2021","unstructured":"Simms L, Mason E, Berg EL, et al.. Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes. Curr Res Toxicol. 2021, 2:309-21. 10.1016\/j.crtox.2021.08.003","journal-title":"Curr Res Toxicol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83511-7","article-title":"Impact of cigarette versus electronic cigarette aerosol conditioned media on aortic endothelial cells in a microfluidic cardiovascular model","volume":"11","author":"Makwana O","year":"2021","unstructured":"Makwana O, Smith GA, Flockton HE, Watters GP, Lowe F, Breheny D. Impact of cigarette versus electronic cigarette aerosol conditioned media on aortic endothelial cells in a microfluidic cardiovascular model. Sci Rep. 2021, 11:4747. 10.1038\/s41598-021-83511-7","journal-title":"Sci Rep"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1395670","article-title":"Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products","volume":"6","author":"Chapman F","year":"2024","unstructured":"Chapman F, de Haan L, Gijzen L, et al.. Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products. Front Toxicol. 2024, 6:1395670. 10.3389\/ftox.2024.1395670","journal-title":"Front Toxicol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105582","article-title":"Human vasculature-on-a-chip with macrophage-mediated endothelial activation: the biological effect of aerosol from heated tobacco products on monocyte adhesion","volume":"89","author":"Ohashi K","year":"2023","unstructured":"Ohashi K, Hayashida A, Nozawa A, Matsumura K, Ito S. Human vasculature-on-a-chip with macrophage-mediated endothelial activation: the biological effect of aerosol from heated tobacco products on monocyte adhesion. Toxicol In Vitro. 2023, 89:105582. 10.1016\/j.tiv.2023.105582","journal-title":"Toxicol In Vitro"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102150","article-title":"Comparative study of the effects of cigarette smoke versus next generation tobacco and nicotine product extracts on endothelial function","volume":"47","author":"Giebe S","year":"2021","unstructured":"Giebe S, Hofmann A, Brux M, Lowe F, Breheny D, Morawietz H, Brunssen C. Comparative study of the effects of cigarette smoke versus next generation tobacco and nicotine product extracts on endothelial function. Redox Biol. 2021, 47:102150. 10.1016\/j.redox.2021.102150","journal-title":"Redox Biol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1811301","article-title":"3D human microvessel-on-a-chip model for studying monocyte-to-endothelium adhesion under flow - application in systems toxicology","volume":"37","author":"Poussin C","year":"2020","unstructured":"Poussin C, Kramer B, Lanz HL, et al.. 3D human microvessel-on-a-chip model for studying monocyte-to-endothelium adhesion under flow - application in systems toxicology. ALTEX. 2020, 37:47-63. 10.14573\/altex.1811301","journal-title":"ALTEX"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2015.11.007","article-title":"Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells","volume":"339","author":"Poussin C","year":"2016","unstructured":"Poussin C, Laurent A, Peitsch MC, Hoeng J, De Leon H. Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells. Toxicology. 2016, 339:73-86. 10.1016\/j.tox.2015.11.007","journal-title":"Toxicology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.07.025","article-title":"In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation- and cytotoxicity-associated mechanisms promoting adhesion of monocytic cells to human coronary arterial endothelial cells","volume":"120","author":"Poussin C","year":"2018","unstructured":"Poussin C, Laurent A, Kondylis A, et al.. In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation- and cytotoxicity-associated mechanisms promoting adhesion of monocytic cells to human coronary arterial endothelial cells. Food Chem Toxicol. 2018, 120:390-406. 10.1016\/j.fct.2018.07.025","journal-title":"Food Chem Toxicol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-021-03123-y","article-title":"Systems toxicology study reveals reduced impact of heated tobacco product aerosol extract relative to cigarette smoke on premature aging and exacerbation effects in aged aortic cells in vitro","volume":"95","author":"Poussin C","year":"2021","unstructured":"Poussin C, van der Toorn M, Scheuner S, et al.. Systems toxicology study reveals reduced impact of heated tobacco product aerosol extract relative to cigarette smoke on premature aging and exacerbation effects in aged aortic cells in vitro. Arch Toxicol. 2021, 95:3341-59. 10.1007\/s00204-021-03123-y","journal-title":"Arch Toxicol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2025.1658093","article-title":"Monocyte migration assay using a vascular-on-a-chip model and its utilization for the evaluation of a heated tobacco product","volume":"7","author":"Hayashida A","year":"2025","unstructured":"Hayashida A, Nozawa A, Ito S. Monocyte migration assay using a vascular-on-a-chip model and its utilization for the evaluation of a heated tobacco product. Front Toxicol. 2025, 7:1658093. 10.3389\/ftox.2025.1658093","journal-title":"Front Toxicol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfv243","article-title":"An 8-month systems toxicology inhalation\/cessation study in Apoe-\/- mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, THS 2.2, compared with conventional cigarettes","volume":"149","author":"Phillips B","year":"2016","unstructured":"Phillips B, Veljkovic E, Bou\u00e9 S, et al.. An 8-month systems toxicology inhalation\/cessation study in Apoe-\/- mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, THS 2.2, compared with conventional cigarettes. Toxicol Sci. 2016, 149:411-32. 10.1093\/toxsci\/kfv243","journal-title":"Toxicol Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.06.009","article-title":"Mouse models of atherosclerosis in translational research","volume":"43","author":"Ilyas I","year":"2022","unstructured":"Ilyas I, Little PJ, Liu Z, et al.. Mouse models of atherosclerosis in translational research. Trends Pharmacol Sci. 2022, 43:920-39. 10.1016\/j.tips.2022.06.009","journal-title":"Trends Pharmacol Sci"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-020-00829-5","article-title":"Mouse models of atherosclerosis and their suitability for the study of myocardial infarction","volume":"115","author":"Golforoush P","year":"2020","unstructured":"Golforoush P, Yellon DM, Davidson SM. Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol. 2020, 115:73. 10.1007\/s00395-020-00829-5","journal-title":"Basic Res Cardiol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.02.008","article-title":"A six-month systems toxicology inhalation\/cessation study in ApoE(-\/-) mice to investigate cardiovascular and respiratory exposure effects of modified risk tobacco products, CHTP 1.2 and THS 2.2, compared with conventional cigarettes","volume":"126","author":"Phillips B","year":"2019","unstructured":"Phillips B, Szostak J, Titz B, et al.. A six-month systems toxicology inhalation\/cessation study in ApoE(-\/-) mice to investigate cardiovascular and respiratory exposure effects of modified risk tobacco products, CHTP 1.2 and THS 2.2, compared with conventional cigarettes. Food Chem Toxicol. 2019, 126:113-41. 10.1016\/j.fct.2019.02.008","journal-title":"Food Chem Toxicol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108887","article-title":"Structural, functional, and molecular impact on the cardiovascular system in ApoE(-\/-) mice exposed to aerosol from candidate modified risk tobacco products, Carbon Heated Tobacco Product 1.2 and Tobacco Heating System 2.2, compared with cigarette smoke","volume":"315","author":"Szostak J","year":"2020","unstructured":"Szostak J, Titz B, Schlage WK, et al.. Structural, functional, and molecular impact on the cardiovascular system in ApoE(-\/-) mice exposed to aerosol from candidate modified risk tobacco products, Carbon Heated Tobacco Product 1.2 and Tobacco Heating System 2.2, compared with cigarette smoke. Chem Biol Interact. 2020, 315:108887. 10.1016\/j.cbi.2019.108887","journal-title":"Chem Biol Interact"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00613.2019","article-title":"A 6-month systems toxicology inhalation study in ApoE(-\/-) mice demonstrates reduced cardiovascular effects of E-vapor aerosols compared with cigarette smoke","volume":"318","author":"Szostak J","year":"2020","unstructured":"Szostak J, Wong ET, Titz B, et al.. A 6-month systems toxicology inhalation study in ApoE(-\/-) mice demonstrates reduced cardiovascular effects of E-vapor aerosols compared with cigarette smoke. Am J Physiol Heart Circ Physiol. 2020, 318:H604-31. 10.1152\/ajpheart.00613.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-021-03020-4","article-title":"A 6-month inhalation toxicology study in Apoe(-\/-) mice demonstrates substantially lower effects of e-vapor aerosol compared with cigarette smoke in the respiratory tract","volume":"95","author":"Wong ET","year":"2021","unstructured":"Wong ET, Szostak J, Titz B, et al.. A 6-month inhalation toxicology study in Apoe(-\/-) mice demonstrates substantially lower effects of e-vapor aerosol compared with cigarette smoke in the respiratory tract. Arch Toxicol. 2021, 95:1805-29. 10.1007\/s00204-021-03020-4","journal-title":"Arch Toxicol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00492.2025","article-title":"Conventional tobacco and electronic cigarettes differentially affect cardiovascular health in male and female mice","volume":"329","author":"Lao CJ","year":"2025","unstructured":"Lao CJ, Jordan MC, Rivera JC, et al.. Conventional tobacco and electronic cigarettes differentially affect cardiovascular health in male and female mice. Am J Physiol Heart Circ Physiol. 2025, 329:H1162-73. 10.1152\/ajpheart.00492.2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.03.010","article-title":"Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes","volume":"89","author":"Asrafuzzaman M","year":"2017","unstructured":"Asrafuzzaman M, Cao Y, Afroz R, Kamato D, Gray S, Little PJ. Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes. Biomed Pharmacother. 2017, 89:1242-51. 10.1016\/j.biopha.2017.03.010","journal-title":"Biomed Pharmacother"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00713.2017","article-title":"Chronic exposure to electronic cigarettes results in impaired cardiovascular function in mice","volume":"124","author":"Olfert IM","year":"2018","unstructured":"Olfert IM, DeVallance E, Hoskinson H, et al.. Chronic exposure to electronic cigarettes results in impaired cardiovascular function in mice. J Appl Physiol (1985). 2018, 124:573-82. 10.1152\/japplphysiol.00713.2017","journal-title":"J Appl Physiol (1985)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfaa131","article-title":"Reduced chronic toxicity and carcinogenicity in A\/J mice in response to life-time exposure to aerosol from a heated tobacco product compared with cigarette smoke","volume":"178","author":"Wong ET","year":"2020","unstructured":"Wong ET, Luettich K, Krishnan S, et al.. Reduced chronic toxicity and carcinogenicity in A\/J mice in response to life-time exposure to aerosol from a heated tobacco product compared with cigarette smoke. Toxicol Sci. 2020, 178:44-70. 10.1093\/toxsci\/kfaa131","journal-title":"Toxicol Sci"},{"key":"ref80","unstructured":"Organisation for Economic Co-operation and Development. guidance document for the scientific review of adverse outcome pathways. (2021). Accessed: 5th January 2026: https:\/\/www.oecd.org\/content\/dam\/oecd\/en\/publications\/reports\/2021\/12\/guidance-document-for-the-scientific-review-of-...."},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.08.012","article-title":"An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework","volume":"48","author":"Ding R","year":"2023","unstructured":"Ding R, Ren X, Sun Q, Sun Z, Duan J. An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework. J Adv Res. 2023, 48:227-57. 10.1016\/j.jare.2022.08.012","journal-title":"J Adv Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2018.05.001","article-title":"Assessment of the exposure to harmful and potentially harmful constituents in healthy Japanese smokers using a novel tobacco vapor product compared with conventional cigarettes and smoking abstinence","volume":"96","author":"Yuki D","year":"2018","unstructured":"Yuki D, Takeshige Y, Nakaya K, Futamura Y. Assessment of the exposure to harmful and potentially harmful constituents in healthy Japanese smokers using a novel tobacco vapor product compared with conventional cigarettes and smoking abstinence. Regul Toxicol Pharmacol. 2018, 96:127-34. 10.1016\/j.yrtph.2018.05.001","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty140","article-title":"Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum","volume":"21","author":"Round EK","year":"2019","unstructured":"Round EK, Chen P, Taylor AK, Schmidt E. Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum. Nicotine Tob Res. 2019, 21:1239-47. 10.1093\/ntr\/nty140","journal-title":"Nicotine Tob Res"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.26324","article-title":"Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among African American and Latinx smokers: a randomized clinical trial","volume":"3","author":"Pulvers K","year":"2020","unstructured":"Pulvers K, Nollen NL, Rice M, Schmid CH, Qu K, Benowitz NL, Ahluwalia JS. Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among African American and Latinx smokers: a randomized clinical trial. JAMA Netw Open. 2020, 3:e2026324. 10.1001\/jamanetworkopen.2020.26324","journal-title":"JAMA Netw Open"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0058","article-title":"Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein","volume":"8","author":"McRobbie H","year":"2015","unstructured":"McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, Hajek P. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila). 2015, 8:873-8. 10.1158\/1940-6207.CAPR-15-0058","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab069","article-title":"Harm reduction associated with dual use of cigarettes and e-cigarettes in black and latino smokers: secondary analyses from a randomized controlled e-cigarette switching trial","volume":"23","author":"Arnold MJ","year":"2021","unstructured":"Arnold MJ, Nollen NL, Mayo MS, et al.. Harm reduction associated with dual use of cigarettes and e-cigarettes in black and latino smokers: secondary analyses from a randomized controlled e-cigarette switching trial. Nicotine Tob Res. 2021, 23:1972-6. 10.1093\/ntr\/ntab069","journal-title":"Nicotine Tob Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab134","article-title":"Changes in biomarkers of cigarette smoke exposure after 6 days of switching exclusively or partially to use of the JUUL system with two nicotine concentrations: a randomized controlled confinement study in adult smokers","volume":"23","author":"Cohen G","year":"2021","unstructured":"Cohen G, Goldenson NI, Bailey PC, Chan S, Shiffman S. Changes in biomarkers of cigarette smoke exposure after 6 days of switching exclusively or partially to use of the JUUL system with two nicotine concentrations: a randomized controlled confinement study in adult smokers. Nicotine Tob Res. 2021, 23:2153-61. 10.1093\/ntr\/ntab134","journal-title":"Nicotine Tob Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.10.003","article-title":"A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12\u00a0weeks","volume":"81 Suppl 1","author":"Cravo AS","year":"2016","unstructured":"Cravo AS, Bush J, Sharma G, Savioz R, Martin C, Craige S, Walele T. A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12\u00a0weeks. Regul Toxicol Pharmacol. 2016, 81 Suppl 1:S1-S14. 10.1016\/j.yrtph.2016.10.003","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3236-1","article-title":"Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes","volume":"16","author":"D'Ruiz CD","year":"2016","unstructured":"D'Ruiz CD, Graff DW, Robinson E. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016, 16:543. 10.1186\/s12889-016-3236-1","journal-title":"BMC Public Health"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac029","article-title":"Biomarkers of exposure and biomarkers of potential harm in adult smokers who switch to e-vapor products relative to cigarette smoking in a 24-week, randomized, clinical trial","volume":"24","author":"Edmiston JS","year":"2022","unstructured":"Edmiston JS, Webb KM, Wang J, Oliveri D, Liang Q, Sarkar M. Biomarkers of exposure and biomarkers of potential harm in adult smokers who switch to e-vapor products relative to cigarette smoking in a 24-week, randomized, clinical trial. Nicotine Tob Res. 2022, 24:1047-54. 10.1093\/ntr\/ntac029","journal-title":"Nicotine Tob Res"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw160","article-title":"Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study","volume":"19","author":"Goniewicz ML","year":"2017","unstructured":"Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P 3rd, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017, 19:160-7. 10.1093\/ntr\/ntw160","journal-title":"Nicotine Tob Res"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz206","article-title":"Five-day changes in biomarkers of exposure among adult smokers after completely switching from combustible cigarettes to a nicotine-salt pod system","volume":"22","author":"Jay J","year":"2020","unstructured":"Jay J, Pfaunmiller EL, Huang NJ, Cohen G, Graff DW. Five-day changes in biomarkers of exposure among adult smokers after completely switching from combustible cigarettes to a nicotine-salt pod system. Nicotine Tob Res. 2020, 22:1285-93. 10.1093\/ntr\/ntz206","journal-title":"Nicotine Tob Res"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25054-z","article-title":"Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence","volume":"12","author":"Kanobe MN","year":"2022","unstructured":"Kanobe MN, Jones BA, Nelson P, et al.. Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence. Sci Rep. 2022, 12:20658. 10.1038\/s41598-022-25054-z","journal-title":"Sci Rep"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11070564","article-title":"Changes in biomarkers of exposure and potential harm in smokers switched to Vuse Vibe or Vuse Ciro electronic nicotine delivery systems","volume":"11","author":"Kanobe MN","year":"2023","unstructured":"Kanobe MN, Nelson PR, Brown BG, et al.. Changes in biomarkers of exposure and potential harm in smokers switched to Vuse Vibe or Vuse Ciro electronic nicotine delivery systems. Toxics. 2023, 11:10.3390\/toxics11070564","journal-title":"Toxics"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03518-y","article-title":"Changes in biomarkers of exposure and withdrawal symptom among Chinese adult smokers after completely or partially switching from combustible cigarettes to an electronic nicotine delivery system","volume":"19","author":"Li C","year":"2024","unstructured":"Li C, Guo Y, Duan K, et al.. Changes in biomarkers of exposure and withdrawal symptom among Chinese adult smokers after completely or partially switching from combustible cigarettes to an electronic nicotine delivery system. Intern Emerg Med. 2024, 19:669-79. 10.1007\/s11739-023-03518-y","journal-title":"Intern Emerg Med"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2021.05.003","article-title":"A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation","volume":"8","author":"McEwan M","year":"2021","unstructured":"McEwan M, Gale N, Ebajemito JK, Camacho OM, Hardie G, Proctor CJ, Murphy J. A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation. Toxicol Rep. 2021, 8:994-1001. 10.1016\/j.toxrep.2021.05.003","journal-title":"Toxicol Rep"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02813-w","article-title":"Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu(\u2122) electronic nicotine delivery systems (ENDS)","volume":"17","author":"Morris P","year":"2022","unstructured":"Morris P, McDermott S, Chapman F, et al.. Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu(\u2122) electronic nicotine delivery systems (ENDS). Intern Emerg Med. 2022, 17:397-410. 10.1007\/s11739-021-02813-w","journal-title":"Intern Emerg Med"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2017.12.010","article-title":"Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting","volume":"92","author":"Walele T","year":"2018","unstructured":"Walele T, Bush J, Koch A, Savioz R, Martin C, O'Connell G. Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regul Toxicol Pharmacol. 2018, 92:226-38. 10.1016\/j.yrtph.2017.12.010","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47891","article-title":"Exposure to toxicants associated with use and transitions between cigarettes, e-cigarettes, and no tobacco","volume":"5","author":"Dai H","year":"2022","unstructured":"Dai H, Benowitz NL, Achutan C, Farazi PA, Degarege A, Khan AS. Exposure to toxicants associated with use and transitions between cigarettes, e-cigarettes, and no tobacco. JAMA Netw Open. 2022, 5:e2147891. 10.1001\/jamanetworkopen.2021.47891","journal-title":"JAMA Netw Open"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2016.1196282","article-title":"Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers","volume":"26","author":"O'Connell G","year":"2016","unstructured":"O'Connell G, Graff DW, D'Ruiz CD. Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Toxicol Mech Methods. 2016, 26:443-54. 10.1080\/15376516.2016.1196282","journal-title":"Toxicol Mech Methods"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae177","article-title":"Impact of heating conventional cigarettes with a novel device on health-related biomarkers and cigarette use patterns among Chinese adult smokers unwilling to quit: a pilot randomized controlled trial","volume":"27","author":"Chu S","year":"2025","unstructured":"Chu S, Li X, Zhang D, et al.. Impact of heating conventional cigarettes with a novel device on health-related biomarkers and cigarette use patterns among Chinese adult smokers unwilling to quit: a pilot randomized controlled trial. Nicotine Tob Res. 2025, 27:873-83. 10.1093\/ntr\/ntae177","journal-title":"Nicotine Tob Res"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2024.2358318","article-title":"Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial","volume":"29","author":"Ansari SM","year":"2024","unstructured":"Ansari SM, Hession PS, David M, Blanc N, de La Bourdonnaye G, Pouly S, Haziza C. Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial. Biomarkers. 2024, 29:298-314. 10.1080\/1354750X.2024.2358318","journal-title":"Biomarkers"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11100816","article-title":"Comparison of biomarkers of exposure in a controlled study of smokers switched from conventional cigarettes to heated tobacco products","volume":"11","author":"Li X","year":"2023","unstructured":"Li X, Wang X, Cui P, Liu G, Zhang H, Gao Y, Kai Z. Comparison of biomarkers of exposure in a controlled study of smokers switched from conventional cigarettes to heated tobacco products. Toxics. 2023, 11:10.3390\/toxics11100816","journal-title":"Toxics"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1322","article-title":"A randomized control study in healthy adult smokers to assess reduced exposure to selected cigarette smoke constituents in switching to the novel heated tobacco product DT3.0a","volume":"13","author":"Nishihara D","year":"2024","unstructured":"Nishihara D, Yuki D, Suzuki T, Sakaguchi C, Nagata Y, Kakehi A. A randomized control study in healthy adult smokers to assess reduced exposure to selected cigarette smoke constituents in switching to the novel heated tobacco product DT3.0a. Clin Pharmacol Drug Dev. 2024, 13:45-57. 10.1002\/cpdd.1322","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22997-1","article-title":"Assessment of the exposure to selected smoke constituents in adult smokers using in-market heated tobacco products: a randomized, controlled study","volume":"12","author":"Yuki D","year":"2022","unstructured":"Yuki D, Kikuchi A, Suzuki T, Sakaguchi C, Huangfu D, Nagata Y, Kakehi A. Assessment of the exposure to selected smoke constituents in adult smokers using in-market heated tobacco products: a randomized, controlled study. Sci Rep. 2022, 12:18167. 10.1038\/s41598-022-22997-1","journal-title":"Sci Rep"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-022-03062-1","article-title":"Changes in biomarkers of exposure and biomarkers of potential harm after 360\u00a0days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking","volume":"17","author":"Gale N","year":"2022","unstructured":"Gale N, McEwan M, Hardie G, Proctor CJ, Murphy J. Changes in biomarkers of exposure and biomarkers of potential harm after 360\u00a0days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking. Intern Emerg Med. 2022, 17:2017-30. 10.1007\/s11739-022-03062-1","journal-title":"Intern Emerg Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02798-6","article-title":"Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial","volume":"16","author":"Gale N","year":"2021","unstructured":"Gale N, McEwan M, Camacho OM, Hardie G, Proctor CJ, Murphy J. Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Intern Emerg Med. 2021, 16:2201-12. 10.1007\/s11739-021-02798-6","journal-title":"Intern Emerg Med"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaa135","article-title":"Changes in biomarkers of exposure on switching from a conventional cigarette to the glo tobacco heating product: a randomized, controlled ambulatory study","volume":"23","author":"Gale N","year":"2021","unstructured":"Gale N, McEwan M, Camacho OM, Hardie G, Murphy J, Proctor CJ. Changes in biomarkers of exposure on switching from a conventional cigarette to the glo tobacco heating product: a randomized, controlled ambulatory study. Nicotine Tob Res. 2021, 23:584-91. 10.1093\/ntr\/ntaa135","journal-title":"Nicotine Tob Res"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2020.04.013","article-title":"Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product","volume":"330","author":"Bosilkovska M","year":"2020","unstructured":"Bosilkovska M, Tran CT, de La Bourdonnaye G, Taranu B, Benzimra M, Haziza C. Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product. Toxicol Lett. 2020, 330:30-40. 10.1016\/j.toxlet.2020.04.013","journal-title":"Toxicol Lett"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0915","article-title":"Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial","volume":"28","author":"L\u00fcdicke F","year":"2019","unstructured":"L\u00fcdicke F, Ansari SM, Lama N, et al.. Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2019, 28:1934-43. 10.1158\/1055-9965.EPI-18-0915","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz084","article-title":"Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the Menthol Tobacco Heating System 2.2 for 3 months (Part 2)","volume":"22","author":"Haziza C","year":"2020","unstructured":"Haziza C, de La Bourdonnaye G, Donelli A, et al.. Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the Menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine Tob Res. 2020, 22:549-59. 10.1093\/ntr\/ntz084","journal-title":"Nicotine Tob Res"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz013","article-title":"Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the Menthol Tobacco Heating System 2.2 for 3 months (part 1)","volume":"22","author":"Haziza C","year":"2020","unstructured":"Haziza C, de La Bourdonnaye G, Donelli A, et al.. Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the Menthol Tobacco Heating System 2.2 for 3 months (part 1). Nicotine Tob Res. 2020, 22:539-48. 10.1093\/ntr\/ntz013","journal-title":"Nicotine Tob Res"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty104","article-title":"Changes in biomarkers of exposure on switching from a conventional cigarette to tobacco heating products: a randomized, controlled study in healthy Japanese subjects","volume":"21","author":"Gale N","year":"2019","unstructured":"Gale N, McEwan M, Eldridge AC, et al.. Changes in biomarkers of exposure on switching from a conventional cigarette to tobacco heating products: a randomized, controlled study in healthy Japanese subjects. Nicotine Tob Res. 2019, 21:1220-7. 10.1093\/ntr\/nty104","journal-title":"Nicotine Tob Res"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx028","article-title":"Effects of switching to the Menthol Tobacco Heating System 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (part 2)","volume":"20","author":"L\u00fcdicke F","year":"2018","unstructured":"L\u00fcdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, Weitkunat R. Effects of switching to the Menthol Tobacco Heating System 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (part 2). Nicotine Tob Res. 2018, 20:173-82. 10.1093\/ntr\/ntx028","journal-title":"Nicotine Tob Res"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw287","article-title":"Effects of switching to the Tobacco Heating System 2.2 Menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (part 1)","volume":"20","author":"L\u00fcdicke F","year":"2018","unstructured":"L\u00fcdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, Weitkunat R. Effects of switching to the Tobacco Heating System 2.2 Menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (part 1). Nicotine Tob Res. 2018, 20:161-72. 10.1093\/ntr\/ntw287","journal-title":"Nicotine Tob Res"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2016.11.047","article-title":"Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days","volume":"10","author":"Haziza C","year":"2017","unstructured":"Haziza C, de La Bourdonnaye G, Skiada D, Ancerewicz J, Baker G, Picavet P, L\u00fcdicke F. Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days. Data Brief. 2017, 10:283-93. 10.1016\/j.dib.2016.11.047","journal-title":"Data Brief"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.11.011","article-title":"Evaluation of the Tobacco Heating System 2.2. Part 9: application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2","volume":"81 Suppl 2","author":"Martin F","year":"2016","unstructured":"Martin F, Talikka M, Ivanov NV, Haziza C, Hoeng J, Peitsch MC. Evaluation of the Tobacco Heating System 2.2. Part 9: application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2. Regul Toxicol Pharmacol. 2016, 81 Suppl 2:S151-7. 10.1016\/j.yrtph.2016.11.011","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.11.003","article-title":"Evaluation of the Tobacco Heating System 2.2. Part 8: 5-day randomized reduced exposure clinical study in Poland","volume":"81 Suppl 2","author":"Haziza C","year":"2016","unstructured":"Haziza C, de La Bourdonnaye G, Skiada D, Ancerewicz J, Baker G, Picavet P, L\u00fcdicke F. Evaluation of the Tobacco Heating System 2.2. Part 8: 5-day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharmacol. 2016, 81 Suppl 2:S139-50. 10.1016\/j.yrtph.2016.11.003","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.09.014","article-title":"Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: a randomized controlled study in confinement","volume":"81","author":"Haziza C","year":"2016","unstructured":"Haziza C, de La Bourdonnaye G, Merlet S, et al.. Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: a randomized controlled study in confinement. Regul Toxicol Pharmacol. 2016, 81:489-99. 10.1016\/j.yrtph.2016.09.014","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw164","article-title":"Reduced exposure to harmful and potentially harmful smoke constituents with the Tobacco Heating System 2.1","volume":"19","author":"L\u00fcdicke F","year":"2017","unstructured":"L\u00fcdicke F, Baker G, Magnette J, Picavet P, Weitkunat R. Reduced exposure to harmful and potentially harmful smoke constituents with the Tobacco Heating System 2.1. Nicotine Tob Res. 2017, 19:168-75. 10.1093\/ntr\/ntw164","journal-title":"Nicotine Tob Res"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw022","article-title":"Evaluation of biomarkers of exposure in smokers switching to a carbon-heated tobacco product: a controlled, randomized, open-label 5-day exposure study","volume":"18","author":"L\u00fcdicke F","year":"2016","unstructured":"L\u00fcdicke F, Haziza C, Weitkunat R, Magnette J. Evaluation of biomarkers of exposure in smokers switching to a carbon-heated tobacco product: a controlled, randomized, open-label 5-day exposure study. Nicotine Tob Res. 2016, 18:1606-13. 10.1093\/ntr\/ntw022","journal-title":"Nicotine Tob Res"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2015.1094134","article-title":"Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure","volume":"20","author":"Ogden MW","year":"2015","unstructured":"Ogden MW, Marano KM, Jones BA, Morgan WT, Stiles MF. Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers. 2015, 20:391-403. 10.3109\/1354750X.2015.1094134","journal-title":"Biomarkers"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.04.016","article-title":"Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting","volume":"69","author":"Sakaguchi C","year":"2014","unstructured":"Sakaguchi C, Kakehi A, Minami N, Kikuchi A, Futamura Y. Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting. Regul Toxicol Pharmacol. 2014, 69:338-47. 10.1016\/j.yrtph.2014.04.016","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.08.006","article-title":"Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland","volume":"64","author":"Martin Leroy C","year":"2012","unstructured":"Martin Leroy C, Jarus-Dziedzic K, Ancerewicz J, Lindner D, Kulesza A, Magnette J. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regul Toxicol Pharmacol. 2012, 64:S74-84. 10.1016\/j.yrtph.2012.08.006","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.08.007","article-title":"Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-day randomized clinical trial of a menthol cigarette in Japan","volume":"64","author":"Tricker AR","year":"2012","unstructured":"Tricker AR, Kanada S, Takada K, Martin Leroy C, Lindner D, Schorp MK, Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-day randomized clinical trial of a menthol cigarette in Japan. Regul Toxicol Pharmacol. 2012, 64:S64-73. 10.1016\/j.yrtph.2012.08.007","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.08.013","article-title":"Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: eight-day randomized clinical trial in Korea","volume":"64","author":"Tricker AR","year":"2012","unstructured":"Tricker AR, Jang IJ, Martin Leroy C, Lindner D, Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: eight-day randomized clinical trial in Korea. Regul Toxicol Pharmacol. 2012, 64:S45-53. 10.1016\/j.yrtph.2012.08.013","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.08.003","article-title":"Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-day randomized clinical trial in Japan","volume":"64","author":"Tricker AR","year":"2012","unstructured":"Tricker AR, Kanada S, Takada K, Leroy CM, Lindner D, Schorp MK, Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-day randomized clinical trial in Japan. Regul Toxicol Pharmacol. 2012, 64:S54-63. 10.1016\/j.yrtph.2012.08.003","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.08.010","article-title":"Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: eight-day randomized clinical trial in the UK","volume":"64","author":"Tricker AR","year":"2012","unstructured":"Tricker AR, Stewart AJ, Leroy CM, Lindner D, Schorp MK, Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: eight-day randomized clinical trial in the UK. Regul Toxicol Pharmacol. 2012, 64:S35-44. 10.1016\/j.yrtph.2012.08.010","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2008.05.016","article-title":"Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers","volume":"52","author":"Frost-Pineda K","year":"2008","unstructured":"Frost-Pineda K, Zedler BK, Oliveri D, Feng S, Liang Q, Roethig HJ. Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol. 2008, 52:104-10. 10.1016\/j.yrtph.2008.05.016","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2008.05.015","article-title":"12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers","volume":"52","author":"Frost-Pineda K","year":"2008","unstructured":"Frost-Pineda K, Zedler BK, Oliveri D, Liang Q, Feng S, Roethig HJ. 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol. 2008, 52:111-7. 10.1016\/j.yrtph.2008.05.015","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2293","article-title":"A randomized, controlled study to assess changes in biomarkers of exposures among adults who smoke that switch to oral nicotine pouch products relative to continuing smoking or stopping all tobacco use","volume":"63","author":"Rensch J","year":"2023","unstructured":"Rensch J, Edmiston J, Wang J, Jin X, Sarkar M. A randomized, controlled study to assess changes in biomarkers of exposures among adults who smoke that switch to oral nicotine pouch products relative to continuing smoking or stopping all tobacco use. J Clin Pharmacol. 2023, 63:1108-18. 10.1002\/jcph.2293","journal-title":"J Clin Pharmacol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2098","article-title":"A randomized, controlled study to assess biomarkers of exposure in adult smokers switching to oral nicotine products","volume":"62","author":"Edmiston J","year":"2022","unstructured":"Edmiston J, Liu J, Wang J, Sarkar M. A randomized, controlled study to assess biomarkers of exposure in adult smokers switching to oral nicotine products. J Clin Pharmacol. 2022, 62:1445-58. 10.1002\/jcph.2098","journal-title":"J Clin Pharmacol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntu082","article-title":"Comparison of consumption patterns, biomarkers of exposure, and subjective effects in cigarette smokers who switched to dissolvable tobacco (Camel Orbs), dual use, or tobacco abstinence","volume":"16","author":"Krautter GR","year":"2014","unstructured":"Krautter GR, Borgerding MF. Comparison of consumption patterns, biomarkers of exposure, and subjective effects in cigarette smokers who switched to dissolvable tobacco (Camel Orbs), dual use, or tobacco abstinence. Nicotine Tob Res. 2014, 16:1336-47. 10.1093\/ntr\/ntu082","journal-title":"Nicotine Tob Res"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2024.2448493","article-title":"Changes in exposure to tobacco-related harmful and potentially harmful constituents among adults who switched completely from smoking cigarettes to use of the JUUL2 system for six days","volume":"30","author":"Goldenson NI","year":"2025","unstructured":"Goldenson NI, Shiffman S, Oliveri D, Liang Q, Black RA. Changes in exposure to tobacco-related harmful and potentially harmful constituents among adults who switched completely from smoking cigarettes to use of the JUUL2 system for six days. Biomarkers. 2025, 30:77-87. 10.1080\/1354750X.2024.2448493","journal-title":"Biomarkers"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2020.586674","article-title":"The evolving e-cigarette: comparative chemical analyses of e-cigarette vapor and cigarette smoke","volume":"2","author":"Cunningham A","year":"2020","unstructured":"Cunningham A, McAdam K, Thissen J, Digard H. The evolving e-cigarette: comparative chemical analyses of e-cigarette vapor and cigarette smoke. Front Toxicol. 2020, 2:586674. 10.3389\/ftox.2020.586674","journal-title":"Front Toxicol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty005","article-title":"Chemical analysis and simulated pyrolysis of Tobacco Heating System 2.2 compared to conventional cigarettes","volume":"21","author":"Li X","year":"2019","unstructured":"Li X, Luo Y, Jiang X, et al.. Chemical analysis and simulated pyrolysis of Tobacco Heating System 2.2 compared to conventional cigarettes. Nicotine Tob Res. 2019, 21:111-8. 10.1093\/ntr\/nty005","journal-title":"Nicotine Tob Res"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2008.05.014","article-title":"Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K","volume":"52","author":"Werley MS","year":"2008","unstructured":"Werley MS, Freelin SA, Wrenn SE, et al.. Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. Regul Toxicol Pharmacol. 2008, 52:122-39. 10.1016\/j.yrtph.2008.05.014","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1136\/tc-2022-057802","article-title":"Impact of smoking intensity and device cleaning on IQOS emissions: comparison with an array of cigarettes","volume":"33","author":"Ardati O","year":"2024","unstructured":"Ardati O, Adeniji A, El Hage R, et al.. Impact of smoking intensity and device cleaning on IQOS emissions: comparison with an array of cigarettes. Tob Control. 2024, 33:449-56. 10.1136\/tc-2022-057802","journal-title":"Tob Control"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2025.2461069","article-title":"Differences in biomarkers of potential harm after 2+ years of tobacco heating system use compared to cigarette smoking: a cross-sectional study","volume":"30","author":"Ansari SM","year":"2025","unstructured":"Ansari SM, Leroy P, de La Bourdonnaye G, Pouly S, Reese L, Haziza C. Differences in biomarkers of potential harm after 2+ years of tobacco heating system use compared to cigarette smoking: a cross-sectional study. Biomarkers. 2025, 30:178-91. 10.1080\/1354750X.2025.2461069","journal-title":"Biomarkers"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntad197","article-title":"Comparing adult smokers who switched to JUUL versus continuing smokers: biomarkers of exposure and of potential harm and respiratory symptoms","volume":"26","author":"Shiffman S","year":"2024","unstructured":"Shiffman S, Oliveri DR, Goldenson NI, Liang Q, Black RA, Mishra S. Comparing adult smokers who switched to JUUL versus continuing smokers: biomarkers of exposure and of potential harm and respiratory symptoms. Nicotine Tob Res. 2024, 26:494-502. 10.1093\/ntr\/ntad197","journal-title":"Nicotine Tob Res"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz185","article-title":"Real-world evidence of differences in biomarkers of exposure to select harmful and potentially harmful constituents and biomarkers of potential harm between adult e-vapor users and adult cigarette smokers","volume":"22","author":"Oliveri D","year":"2020","unstructured":"Oliveri D, Liang Q, Sarkar M. Real-world evidence of differences in biomarkers of exposure to select harmful and potentially harmful constituents and biomarkers of potential harm between adult e-vapor users and adult cigarette smokers. Nicotine Tob Res. 2020, 22:1114-22. 10.1093\/ntr\/ntz185","journal-title":"Nicotine Tob Res"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaf103","article-title":"Toxicant and nicotine exposure in pregnant smokers, vapers, and nicotine-replacement users: cross-sectional study","volume":"27","author":"Ussher M","year":"2025","unstructured":"Ussher M, Lewis S, Marczylo T, et al.. Toxicant and nicotine exposure in pregnant smokers, vapers, and nicotine-replacement users: cross-sectional study. Nicotine Tob Res. 2025, 27:1786-94. 10.1093\/ntr\/ntaf103","journal-title":"Nicotine Tob Res"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03294-9","article-title":"Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers","volume":"18","author":"Haswell LE","year":"2023","unstructured":"Haswell LE, Gale N, Brown E, et al.. Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers. Intern Emerg Med. 2023, 18:1359-71. 10.1007\/s11739-023-03294-9","journal-title":"Intern Emerg Med"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5937","article-title":"Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes","volume":"1","author":"Goniewicz ML","year":"2018","unstructured":"Goniewicz ML, Smith DM, Edwards KC, et al.. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018, 1:e185937. 10.1001\/jamanetworkopen.2018.5937","journal-title":"JAMA Netw Open"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1107","article-title":"Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study","volume":"166","author":"Shahab L","year":"2017","unstructured":"Shahab L, Goniewicz ML, Blount BC, et al.. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017, 166:390-400. 10.7326\/M16-1107","journal-title":"Ann Intern Med"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2022.2148747","article-title":"Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers","volume":"28","author":"Azzopardi D","year":"2023","unstructured":"Azzopardi D, Haswell LE, Frosina J, et al.. Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers. Biomarkers. 2023, 28:118-29. 10.1080\/1354750X.2022.2148747","journal-title":"Biomarkers"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008315316","article-title":"A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system","volume":"48","author":"Roethig HJ","year":"2008","unstructured":"Roethig HJ, Feng S, Liang Q, Liu J, Rees WA, Zedler BK. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J Clin Pharmacol. 2008, 48:580-91. 10.1177\/0091270008315316","journal-title":"J Clin Pharmacol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2015.1094135","article-title":"Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect","volume":"20","author":"Ogden MW","year":"2015","unstructured":"Ogden MW, Marano KM, Jones BA, Morgan WT, Stiles MF. Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect. Biomarkers. 2015, 20:404-10. 10.3109\/1354750X.2015.1094135","journal-title":"Biomarkers"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2018.02.002","article-title":"Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: a literature review","volume":"94","author":"Scherer G","year":"2018","unstructured":"Scherer G. Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: a literature review. Regul Toxicol Pharmacol. 2018, 94:203-33. 10.1016\/j.yrtph.2018.02.002","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2017.05.002","article-title":"Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers","volume":"87","author":"D'Ruiz CD","year":"2017","unstructured":"D'Ruiz CD, O'Connell G, Graff DW, Yan XS. Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Regul Toxicol Pharmacol. 2017, 87:36-53. 10.1016\/j.yrtph.2017.05.002","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.04.012","article-title":"Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function","volume":"150","author":"Carnevale R","year":"2016","unstructured":"Carnevale R, Sciarretta S, Violi F, et al.. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016, 150:606-12. 10.1016\/j.chest.2016.04.012","journal-title":"Chest"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010455","article-title":"Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome-vascular assessment of proatherosclerotic effects of smoking ( SUR - VAPES ) 2 randomized trial","volume":"8","author":"Biondi-Zoccai G","year":"2019","unstructured":"Biondi-Zoccai G, Sciarretta S, Bullen C, et al.. Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome-vascular assessment of proatherosclerotic effects of smoking ( SUR - VAPES ) 2 randomized trial. J Am Heart Assoc. 2019, 8:e010455. 10.1161\/JAHA.118.010455","journal-title":"J Am Heart Assoc"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.09.067","article-title":"Cardiovascular effects of switching from\u00a0tobacco cigarettes to electronic\u00a0cigarettes","volume":"74","author":"George J","year":"2019","unstructured":"George J, Hussain M, Vadiveloo T, et al.. Cardiovascular effects of switching from\u00a0tobacco cigarettes to electronic\u00a0cigarettes. J Am Coll Cardiol. 2019, 74:3112-20. 10.1016\/j.jacc.2019.09.067","journal-title":"J Am Coll Cardiol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.948556","article-title":"Effects of heated tobacco use on blood parameters and cardiovascular risk in healthy men","volume":"31","author":"\u015awi\u0105tkowska B","year":"2025","unstructured":"\u015awi\u0105tkowska B, Jankowski M, Kaleta D. Effects of heated tobacco use on blood parameters and cardiovascular risk in healthy men. Med Sci Monit. 2025, 31:e948556. 10.12659\/MSM.948556","journal-title":"Med Sci Monit"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038258","article-title":"Atherogenic effects of acute electronic cigarette compared with tobacco cigarette smoking in people living with HIV: a randomized crossover trial","volume":"14","author":"Kelesidis T","year":"2025","unstructured":"Kelesidis T, Fotooh Abadi L, Ruedisueli I, D'Costa ZU, Middlekauff HR. Atherogenic effects of acute electronic cigarette compared with tobacco cigarette smoking in people living with HIV: a randomized crossover trial. J Am Heart Assoc. 2025, 14:e038258. 10.1161\/JAHA.124.038258","journal-title":"J Am Heart Assoc"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16158","article-title":"Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV","volume":"12","author":"Ruedisueli I","year":"2024","unstructured":"Ruedisueli I, Shi K, Lopez S, Gornbein J, Middlekauff HR. Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV. Physiol Rep. 2024, 12:e16158. 10.14814\/phy2.16158","journal-title":"Physiol Rep"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00067.2023","article-title":"Acute cardiovascular effects of 4th generation electronic cigarettes and combusted cigarettes: implications for harm reduction","volume":"136","author":"Nguyen R","year":"2024","unstructured":"Nguyen R, Ruedisueli I, Lakhani K, Ma J, Middlekauff HR. Acute cardiovascular effects of 4th generation electronic cigarettes and combusted cigarettes: implications for harm reduction. J Appl Physiol (1985). 2024, 136:440-9. 10.1152\/japplphysiol.00067.2023","journal-title":"J Appl Physiol (1985)"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/186932","article-title":"The impact of chronic electronic cigarette use on endothelial dysfunction measured by flow-mediated vasodilation: a systematic review and meta-analysis","volume":"22","author":"Lee J","year":"2024","unstructured":"Lee J, Yao Z, Boakye E, Blaha MJ. The impact of chronic electronic cigarette use on endothelial dysfunction measured by flow-mediated vasodilation: a systematic review and meta-analysis. Tob Induc Dis. 2024, 22:10.18332\/tid\/186932","journal-title":"Tob Induc Dis"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1093\/function\/zqab004","article-title":"E-cigarettes and cardiopulmonary health","volume":"2","author":"Tarran R","year":"2021","unstructured":"Tarran R, Barr RG, Benowitz NL, et al.. E-cigarettes and cardiopulmonary health. Function (Oxf). 2021, 2:zqab004. 10.1093\/function\/zqab004","journal-title":"Function (Oxf)"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.125.073894","article-title":"Predicting cardiovascular risk with use of various tobacco products","volume":"151","author":"Benowitz NL","year":"2025","unstructured":"Benowitz NL. Predicting cardiovascular risk with use of various tobacco products. Circulation. 2025, 151:1006-8. 10.1161\/CIRCULATIONAHA.125.073894","journal-title":"Circulation"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2016-052934","article-title":"Design and methods of the Population Assessment of Tobacco and Health (PATH) study","volume":"26","author":"Hyland A","year":"2017","unstructured":"Hyland A, Ambrose BK, Conway KP, et al.. Design and methods of the Population Assessment of Tobacco and Health (PATH) study. Tob Control. 2017, 26:371-8. 10.1136\/tobaccocontrol-2016-052934","journal-title":"Tob Control"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.05.003","article-title":"Re-examining the association between e-cigarette use and myocardial infarction: a cautionary tale","volume":"61","author":"Critcher CR","year":"2021","unstructured":"Critcher CR, Siegel M. Re-examining the association between e-cigarette use and myocardial infarction: a cautionary tale. Am J Prev Med. 2021, 61:474-82. 10.1016\/j.amepre.2021.05.003","journal-title":"Am J Prev Med"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144005","article-title":"Methodological and statistical considerations for cross-sectional, case-control, and cohort studies","volume":"13","author":"P\u00e9rez-Guerrero EE","year":"2024","unstructured":"P\u00e9rez-Guerrero EE, Guill\u00e9n-Medina MR, M\u00e1rquez-Sandoval F, et al.. Methodological and statistical considerations for cross-sectional, case-control, and cohort studies. J Clin Med. 2024, 13:10.3390\/jcm13144005","journal-title":"J Clin Med"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac037","article-title":"Can cross-sectional studies contribute to causal inference? It depends","volume":"192","author":"Savitz DA","year":"2023","unstructured":"Savitz DA, Wellenius GA. Can cross-sectional studies contribute to causal inference? It depends. Am J Epidemiol. 2023, 192:514-6. 10.1093\/aje\/kwac037","journal-title":"Am J Epidemiol"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-022-03141-3","article-title":"Cross-sectional\u00a0e-cigarette studies are unreliable without timing of exposure and disease diagnosis","volume":"18","author":"Rodu B","year":"2023","unstructured":"Rodu B, Plurphanswat N. Cross-sectional\u00a0e-cigarette studies are unreliable without timing of exposure and disease diagnosis. Intern Emerg Med. 2023, 18:319-23. 10.1007\/s11739-022-03141-3","journal-title":"Intern Emerg Med"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012317","article-title":"Electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health","volume":"8","author":"Bhatta DN","year":"2019","unstructured":"Bhatta DN, Glantz SA. Electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health. J Am Heart Assoc. 2019, 8:e012317. 10.1161\/JAHA.119.012317","journal-title":"J Am Heart Assoc"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014519","article-title":"Retraction to: electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health","volume":"9","year":"2020","unstructured":"Retraction to. electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health. J Am Heart Assoc. 2020, 9:e014519. 10.1161\/JAHA.119.014519","journal-title":"J Am Heart Assoc"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1111\/add.15067","article-title":"A re-analysis of e-cigarette use and heart attacks in PATH wave 1 data","volume":"115","author":"Rodu B","year":"2020","unstructured":"Rodu B, Plurphanswat N. A re-analysis of e-cigarette use and heart attacks in PATH wave 1 data. Addiction. 2020, 115:2176-9. 10.1111\/add.15067","journal-title":"Addiction"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9030052","article-title":"Cross-sectional associations of smoking and e-cigarette use with self-reported diagnosed hypertension: findings from Wave 3 of the Population Assessment of Tobacco and Health Study","volume":"9","author":"Miller CR","year":"2021","unstructured":"Miller CR, Shi H, Li D, Goniewicz ML. Cross-sectional associations of smoking and e-cigarette use with self-reported diagnosed hypertension: findings from Wave 3 of the Population Assessment of Tobacco and Health Study. Toxics. 2021, 9:10.3390\/toxics9030052","journal-title":"Toxics"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-21-0140","article-title":"Biomarkers of inflammation and oxidative stress among adult former smoker, current e-cigarette users-results from Wave 1 PATH study","volume":"30","author":"Christensen CH","year":"2021","unstructured":"Christensen CH, Chang JT, Rostron BL, et al.. Biomarkers of inflammation and oxidative stress among adult former smoker, current e-cigarette users-results from Wave 1 PATH study. Cancer Epidemiol Biomarkers Prev. 2021, 30:1947-55. 10.1158\/1055-9965.EPI-21-0140","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051551","article-title":"Association of cigarette and electronic cigarette use patterns with levels of inflammatory and oxidative stress biomarkers among US adults: Population Assessment of Tobacco and Health study","volume":"143","author":"Stokes AC","year":"2021","unstructured":"Stokes AC, Xie W, Wilson AE, et al.. Association of cigarette and electronic cigarette use patterns with levels of inflammatory and oxidative stress biomarkers among US adults: Population Assessment of Tobacco and Health study. Circulation. 2021, 143:869-71. 10.1161\/CIRCULATIONAHA.120.051551","journal-title":"Circulation"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057369","article-title":"E-cigarette use and risk of cardiovascular disease: a longitudinal analysis of the PATH study (2013-2019)","volume":"145","author":"Berlowitz JB","year":"2022","unstructured":"Berlowitz JB, Xie W, Harlow AF, et al.. E-cigarette use and risk of cardiovascular disease: a longitudinal analysis of the PATH study (2013-2019). Circulation. 2022, 145:1557-9. 10.1161\/CIRCULATIONAHA.121.057369","journal-title":"Circulation"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19074137","article-title":"Cardiovascular outcomes among combustible-tobacco and Electronic Nicotine Delivery System (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) study, 2013-2019","volume":"19","author":"Mahoney MC","year":"2022","unstructured":"Mahoney MC, Rivard C, Kimmel HL, et al.. Cardiovascular outcomes among combustible-tobacco and Electronic Nicotine Delivery System (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) study, 2013-2019. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph19074137","journal-title":"Int J Environ Res Public Health"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac182","article-title":"Longitudinal associations between exclusive and dual use of electronic nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults","volume":"25","author":"Hirschtick JL","year":"2023","unstructured":"Hirschtick JL, Cook S, Patel A, et al.. Longitudinal associations between exclusive and dual use of electronic nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults. Nicotine Tob Res. 2023, 25:386-94. 10.1093\/ntr\/ntac182","journal-title":"Nicotine Tob Res"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027180","article-title":"An association between electronic nicotine delivery systems use and a history of stroke using the 2016 behavioral risk factor surveillance system","volume":"100","author":"Bricknell RA","year":"2021","unstructured":"Bricknell RA, Ducaud C, Figueroa A, et al.. An association between electronic nicotine delivery systems use and a history of stroke using the 2016 behavioral risk factor surveillance system. Medicine (Baltimore). 2021, 100:e27180. 10.1097\/MD.0000000000027180","journal-title":"Medicine (Baltimore)"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.02.016","article-title":"Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers","volume":"132","author":"Osei AD","year":"2019","unstructured":"Osei AD, Mirbolouk M, Orimoloye OA, et al.. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am J Med. 2019, 132:949-954.e2. 10.1016\/j.amjmed.2019.02.016","journal-title":"Am J Med"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.10.008","article-title":"Risk of stroke with e-cigarette and combustible cigarette use in young adults","volume":"58","author":"Parekh T","year":"2020","unstructured":"Parekh T, Pemmasani S, Desai R. Risk of stroke with e-cigarette and combustible cigarette use in young adults. Am J Prev Med. 2020, 58:446-52. 10.1016\/j.amepre.2019.10.008","journal-title":"Am J Prev Med"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.909383","article-title":"The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: findings from behavioral risk factor surveillance system, 2020","volume":"9","author":"Liu X","year":"2022","unstructured":"Liu X, Yuan Z, Ji Y. The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: findings from behavioral risk factor surveillance system, 2020. Front Cardiovasc Med. 2022, 9:909383. 10.3389\/fcvm.2022.909383","journal-title":"Front Cardiovasc Med"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198681","article-title":"Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study","volume":"13","author":"Wang JB","year":"2018","unstructured":"Wang JB, Olgin JE, Nah G, Vittinghoff E, Cataldo JK, Pletcher MJ, Marcus GM. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One. 2018, 13:e0198681. 10.1371\/journal.pone.0198681","journal-title":"PLoS One"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint14020037","article-title":"RETRACTED: effect comparison of e-cigarette and traditional smoking and association with stroke-a cross-sectional study of NHANES","volume":"14","author":"Patel U","year":"2022","unstructured":"Patel U, Patel N, Khurana M, et al.. RETRACTED: effect comparison of e-cigarette and traditional smoking and association with stroke-a cross-sectional study of NHANES. Neurol Int. 2022, 14:441-52. 10.3390\/neurolint14020037","journal-title":"Neurol Int"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17120207","article-title":"RETRACTED: Patel et al. effect comparison of e-cigarette and traditional smoking and association with stroke-a cross-sectional study of NHANES. Neurol. Int. 2022, 14, 441-452","volume":"17","author":"Patel U","year":"2025","unstructured":"Patel U, Patel N, Khurana M, et al.. RETRACTED: Patel et al. effect comparison of e-cigarette and traditional smoking and association with stroke-a cross-sectional study of NHANES. Neurol. Int. 2022, 14, 441-452. Neurol Int. 2025, 17:10.3390\/neurolint17120207","journal-title":"Neurol Int"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319877741","article-title":"Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys","volume":"10","author":"Farsalinos KE","year":"2019","unstructured":"Farsalinos KE, Polosa R, Cibella F, Niaura R. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther Adv Chronic Dis. 2019, 10:2040622319877741. 10.1177\/2040622319877741","journal-title":"Ther Adv Chronic Dis"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol15.16752","article-title":"Hypertension and cardiovascular diseases among electronic and combustible cigarette users","volume":"15","author":"Falk GE","year":"2022","unstructured":"Falk GE, Okut H, Vindhyal MR, Ablah E. Hypertension and cardiovascular diseases among electronic and combustible cigarette users. Kans J Med. 2022, 15:226-30. 10.17161\/kjm.vol15.16752","journal-title":"Kans J Med"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48402","article-title":"Electronic cigarette use and myocardial infarction","volume":"15","author":"Alzahrani T","year":"2023","unstructured":"Alzahrani T. Electronic cigarette use and myocardial infarction. Cureus. 2023, 15:e48402. 10.7759\/cureus.48402","journal-title":"Cureus"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57119","article-title":"Questionable effects of electronic cigarette use on cardiovascular diseases from the national health interview survey (NHIS, 2014-2021)","volume":"16","author":"Plurphanswat N","year":"2024","unstructured":"Plurphanswat N, Selya A, Rodu B. Questionable effects of electronic cigarette use on cardiovascular diseases from the national health interview survey (NHIS, 2014-2021). Cureus. 2024, 16:e57119. 10.7759\/cureus.57119","journal-title":"Cureus"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/175732","article-title":"Electronic cigarette use and chest pain in US adults: evidence from the PATH study","volume":"22","author":"Behrooz L","year":"2024","unstructured":"Behrooz L, Xie W, Goghari A, Robertson R, Bhatnagar A, Stokes A, Hamburg NM. Electronic cigarette use and chest pain in US adults: evidence from the PATH study. Tob Induc Dis. 2024, 22:10.18332\/tid\/175732","journal-title":"Tob Induc Dis"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1809937","article-title":"The \"All of Us\" research program","volume":"381","author":"Denny JC","year":"2019","unstructured":"Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, Dishman E. The \"All of Us\" research program. N Engl J Med. 2019, 381:668-76. 10.1056\/NEJMsr1809937","journal-title":"N Engl J Med"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaf067","article-title":"E-cigarette use and incident cardiometabolic conditions in the all of us research program","volume":"27","author":"Erhabor J","year":"2025","unstructured":"Erhabor J, Yao Z, Tasdighi E, Benjamin EJ, Bhatnagar A, Blaha MJ. E-cigarette use and incident cardiometabolic conditions in the all of us research program. Nicotine Tob Res. 2025, 27:1651-6. 10.1093\/ntr\/ntaf067","journal-title":"Nicotine Tob Res"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62545-3","article-title":"Dual use of electronic and conventional cigarettes is associated with higher cardiovascular risk factors in Korean men","volume":"10","author":"Kim CY","year":"2020","unstructured":"Kim CY, Paek YJ, Seo HG, et al.. Dual use of electronic and conventional cigarettes is associated with higher cardiovascular risk factors in Korean men. Sci Rep. 2020, 10:5612. 10.1038\/s41598-020-62545-3","journal-title":"Sci Rep"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.054967","article-title":"Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study","volume":"144","author":"Choi S","year":"2021","unstructured":"Choi S, Lee K, Park SM. Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study. Circulation. 2021, 144:1528-38. 10.1161\/CIRCULATIONAHA.121.054967","journal-title":"Circulation"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.24.0201","article-title":"Relationship between heated tobacco product use and low-density lipoprotein cholesterol in Korean adults: a cross-sectional study using Korea National Health and Nutrition Examination Survey 2018-2021 (VII-1 and VIII)","volume":"46","author":"Kim M","year":"2025","unstructured":"Kim M, Lee KJ, Choi I, Kim SH, Ryu K. Relationship between heated tobacco product use and low-density lipoprotein cholesterol in Korean adults: a cross-sectional study using Korea National Health and Nutrition Examination Survey 2018-2021 (VII-1 and VIII). Korean J Fam Med. 2025, 46:443-51. 10.4082\/kjfm.24.0201","journal-title":"Korean J Fam Med"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae705","article-title":"Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study","volume":"46","author":"Kang D","year":"2025","unstructured":"Kang D, Choi KH, Kim H, et al.. Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study. Eur Heart J. 2025, 46:84-95. 10.1093\/eurheartj\/ehae705","journal-title":"Eur Heart J"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20230170","article-title":"Metabolomics profiles alterations in cigarette smokers and heated tobacco product users","volume":"34","author":"Harada S","year":"2024","unstructured":"Harada S, Ohmomo H, Matsumoto M, et al.. Metabolomics profiles alterations in cigarette smokers and heated tobacco product users. J Epidemiol. 2024, 34:403-10. 10.2188\/jea.JE20230170","journal-title":"J Epidemiol"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003755","article-title":"Metabolites of glutamate metabolism are associated with incident cardiovascular events in the PREDIMED PREvenci\u00f3n con DIeta MEDiterr\u00e1nea (PREDIMED) trial","volume":"5","author":"Zheng Y","year":"2016","unstructured":"Zheng Y, Hu FB, Ruiz-Canela M, et al.. Metabolites of glutamate metabolism are associated with incident cardiovascular events in the PREDIMED PREvenci\u00f3n con DIeta MEDiterr\u00e1nea (PREDIMED) trial. J Am Heart Assoc. 2016, 5:10.1161\/JAHA.116.003755","journal-title":"J Am Heart Assoc"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65773","article-title":"A scoping review of behavioural studies on heated tobacco products","volume":"16","author":"Fearon IM","year":"2024","unstructured":"Fearon IM, Cordery SF, Fitzpatrick M, et al.. A scoping review of behavioural studies on heated tobacco products. Cureus. 2024, 16:e65773. 10.7759\/cureus.65773","journal-title":"Cureus"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.123.010112","article-title":"No significant change in trend of hospitalizations for acute coronary syndrome in japan before and after introduction of heated tobacco products","volume":"16","author":"Fujiwara H","year":"2023","unstructured":"Fujiwara H, Nakai M, Iwanaga Y. No significant change in trend of hospitalizations for acute coronary syndrome in japan before and after introduction of heated tobacco products. Circ Cardiovasc Qual Outcomes. 2023, 16:e010112. 10.1161\/CIRCOUTCOMES.123.010112","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.37334","article-title":"Heated tobacco product spread and hospitalizations for acute coronary syndrome in Japan","volume":"8","author":"Iwanaga Y","year":"2025","unstructured":"Iwanaga Y, Nakai M, Miyamoto Y, Hirano T, Fujiwara H. Heated tobacco product spread and hospitalizations for acute coronary syndrome in Japan. JAMA Netw Open. 2025, 8:e2537334. 10.1001\/jamanetworkopen.2025.37334","journal-title":"JAMA Netw Open"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae295","article-title":"Prevalence of nicotine pouch use among youth and adults in great britain-analysis of cross-sectional, nationally representative surveys","volume":"28","author":"Brose L","year":"2026","unstructured":"Brose L, Bunce L, Cheeseman H. Prevalence of nicotine pouch use among youth and adults in great britain-analysis of cross-sectional, nationally representative surveys. Nicotine Tob Res. 2026, 28:213-22. 10.1093\/ntr\/ntae295","journal-title":"Nicotine Tob Res"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.1177\/00333549251313668","article-title":"Oral nicotine pouches: rising popularity and state of the science","volume":"141","author":"Felicione NJ","year":"2026","unstructured":"Felicione NJ, Ozga JE, Eversole A, et al.. Oral nicotine pouches: rising popularity and state of the science. Public Health Rep. 2026, 141:55-62. 10.1177\/00333549251313668","journal-title":"Public Health Rep"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/192522","article-title":"Awareness and use of nicotine pouches in a nationwide sample of adults in Poland","volume":"22","author":"Jankowski M","year":"2024","unstructured":"Jankowski M, Rees VW. Awareness and use of nicotine pouches in a nationwide sample of adults in Poland. Tob Induc Dis. 2024, 22:10.18332\/tid\/192522","journal-title":"Tob Induc Dis"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab258","article-title":"Associations of smokeless tobacco use with cardiovascular disease risk: insights from the population assessment of tobacco and health study","volume":"24","author":"Rezk-Hanna M","year":"2022","unstructured":"Rezk-Hanna M, Warda US, Stokes AC, et al.. Associations of smokeless tobacco use with cardiovascular disease risk: insights from the population assessment of tobacco and health study. Nicotine Tob Res. 2022, 24:1063-70. 10.1093\/ntr\/ntab258","journal-title":"Nicotine Tob Res"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.070852","article-title":"Differential associations of cigar, pipe, and smokeless tobacco use versus combustible cigarette use with subclinical markers of inflammation, thrombosis, and atherosclerosis: the Cross-Cohort Collaboration-Tobacco Working Group","volume":"151","author":"Yao Z","year":"2025","unstructured":"Yao Z, Tasdighi E, Dardari ZA, et al.. Differential associations of cigar, pipe, and smokeless tobacco use versus combustible cigarette use with subclinical markers of inflammation, thrombosis, and atherosclerosis: the Cross-Cohort Collaboration-Tobacco Working Group. Circulation. 2025, 151:993-1005. 10.1161\/CIRCULATIONAHA.124.070852","journal-title":"Circulation"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0335-1","article-title":"Snus: a compelling harm reduction alternative to cigarettes","volume":"16","author":"Clarke E","year":"2019","unstructured":"Clarke E, Thompson K, Weaver S, Thompson J, O'Connell G. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J. 2019, 16:62. 10.1186\/s12954-019-0335-1","journal-title":"Harm Reduct J"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-10-36","article-title":"Epidemiological evidence relating snus to health--an updated review based on recent publications","volume":"10","author":"Lee PN","year":"2013","unstructured":"Lee PN. Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduct J. 2013, 10:36. 10.1186\/1477-7517-10-36","journal-title":"Harm Reduct J"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2013.02.010","article-title":"The effect on health of switching from cigarettes to snus - a review","volume":"66","author":"Lee PN","year":"2013","unstructured":"Lee PN. The effect on health of switching from cigarettes to snus - a review. Regul Toxicol Pharmacol. 2013, 66:1-5. 10.1016\/j.yrtph.2013.02.010","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref206","unstructured":"Food and Drug Administration. family smoking prevention and tobacco control act - an overview. (2009). Accessed: 4th November 2025: https:\/\/www.fda.gov\/tobacco-products\/rules-regulations-and-guidance-related-tobacco-products\/family-smoking-preventio...."},{"key":"ref207","unstructured":"Food and Drug Administration. premarket tobacco product applications. (2024). Accessed: 4th November 2025: https:\/\/www.fda.gov\/tobacco-products\/market-and-distribute-tobacco-product\/premarket-tobacco-product-applications.."},{"key":"ref208","unstructured":"Food and Drug Administration. modified risk tobacco products. (2025). Accessed: 4th November 2025: https:\/\/www.fda.gov\/tobacco-products\/advertising-and-promotion\/modified-risk-tobacco-products.."},{"key":"ref209","unstructured":"Food and Drug Administration. e-cigarettes authorized by the FDA. (2025). Accessed: 4th November 2025: https:\/\/digitalmedia.hhs.gov\/tobacco\/hosted\/Authorized-E-Cig-July2025.pdf."},{"key":"ref210","unstructured":"Food and Drug Administration. FDA authorizes marketing of 20 ZYN nicotine pouch products after extensive scientific review. (2025). Accessed: 4th November 2025: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-ext...."},{"key":"ref211","unstructured":"Food and Drug Administration. PMTA scientific review: technical project lead (TPL). (2021). Accessed: 4th November 2025: https:\/\/www.fda.gov\/media\/153255\/download."},{"key":"ref212","unstructured":"Food and Drug Administration. PMTA coversheet: technical project lead review (TPL). (2019). Accessed: 4th November 2025: https:\/\/www.accessdata.fda.gov\/static\/searchtobacco\/2019\/ctp-callahan-pmta-tpl-043019_19_0.pdf."},{"key":"ref213","unstructured":"Food and Drug Administration. scientific review of modified risk tobacco product application (MRTPA) under section 911(d) of the FD&C Act -technical project lead. (2020). Accessed: 4th November 2025: https:\/\/www.fda.gov\/media\/139796\/download."},{"key":"ref214","unstructured":"Food and Drug Administration. Philip Morris Products S.A. modified risk tobacco product (MRTP) applications. (2025). Accessed: 4th November 2025: https:\/\/www.fda.gov\/tobacco-products\/advertising-and-promotion\/philip-morris-products-sa-modified-risk-tobacco-produc...."},{"key":"ref215","unstructured":"Food and Drug Administration. technical project lead review of PMTAs. (2025). Accessed: 4th November 2025: https:\/\/www.accessdata.fda.gov\/static\/searchtobacco\/ZYN\/PMTA_TPL_PM593-PM612_Zyn_01_13_2025_Redacted.pdf."},{"key":"ref216","unstructured":"Food and Drug Administration. technical project lead (TPL) review of PMTAs. (2022). Accessed: 4th November 2025: https:\/\/www.accessdata.fda.gov\/static\/searchtobacco\/2022\/RJRV-TPL-MultipleSTNs.pdf.."},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0342","article-title":"Urinary leukotriene E(4) and 2,3-dinor thromboxane B(2) are biomarkers of potential harm in short-term tobacco switching studies","volume":"28","author":"Makena P","year":"2019","unstructured":"Makena P, Liu G, Chen P, Yates CR, Prasad GL. Urinary leukotriene E(4) and 2,3-dinor thromboxane B(2) are biomarkers of potential harm in short-term tobacco switching studies. Cancer Epidemiol Biomarkers Prev. 2019, 28:2095-105. 10.1158\/1055-9965.EPI-19-0342","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref218","unstructured":"Global Institute for Novel Nicotine. Greece sets a European precedent with science-based regulation of smoke-free products. (2025). Accessed: 27th November 2025: https:\/\/www.ginn.global\/greece-sets-a-european-precedent-with-science-based-regulation-of-smoke-free-products\/."},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab040","article-title":"Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: findings from the 2020 ITC four country smoking and vaping survey","volume":"23","author":"Li L","year":"2021","unstructured":"Li L, Borland R, Cummings KM, et al.. Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: findings from the 2020 ITC four country smoking and vaping survey. Nicotine Tob Res. 2021, 23:1611-6. 10.1093\/ntr\/ntab040","journal-title":"Nicotine Tob Res"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaf240","article-title":"Patterns of e-cigarette use and smoking cessation outcomes: secondary analysis of a large randomised controlled trial to inform clinical advice","volume":"28","author":"Pesola F","year":"2026","unstructured":"Pesola F, Myers Smith K, Przulj D, Ladmore D, Phillips-Waller A, McRobbie H, Hajek P. Patterns of e-cigarette use and smoking cessation outcomes: secondary analysis of a large randomised controlled trial to inform clinical advice. Nicotine Tob Res. 2026, 28:1039-44. 10.1093\/ntr\/ntaf240","journal-title":"Nicotine Tob Res"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17062161","article-title":"Use of multiple tobacco and tobacco-like products including heated tobacco and e-cigarettes in Japan: a cross-sectional assessment of the 2017 JASTIS study","volume":"17","author":"Sugiyama T","year":"2020","unstructured":"Sugiyama T, Tabuchi T. Use of multiple tobacco and tobacco-like products including heated tobacco and e-cigarettes in Japan: a cross-sectional assessment of the 2017 JASTIS study. Int J Environ Res Public Health. 2020, 17:10.3390\/ijerph17062161","journal-title":"Int J Environ Res Public Health"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r2345","article-title":"Vaping overtakes smoking in Britain for first time","volume":"391","author":"Iacobucci G","year":"2025","unstructured":"Iacobucci G. Vaping overtakes smoking in Britain for first time. BMJ. 2025, 391:r2345. 10.1136\/bmj.r2345","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502420-a-narrative-review-of-the-potential-impact-of-next-generation-tobacco-and-nicotine-products-on-cardiovascular-health","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:35:09Z","timestamp":1782891309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502420-a-narrative-review-of-the-potential-impact-of-next-generation-tobacco-and-nicotine-products-on-cardiovascular-health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":222,"URL":"https:\/\/doi.org\/10.7759\/cureus.111861","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}